المؤلفون: Starokozhko, Viktoriia, Vatakuti, Suresh, Schievink, Bauke H., Merema, Marjolijn T., Asplund, Annika, Synnergren, Jane, Aspegren, Anders, Groothuis, Geny M. M.

المصدر: Archives of Toxicology. 91(5):2079-2092

مصطلحات موضوعية: Bioinformatik, Bioinformatics, INF502 Biomarkers, INF502 Biomarkörer

وصف الملف: electronic

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-13046
https://doi.org/10.1007/s00204-016-1865-x
https://doi.org/10.1007/s00204-016-1895-4
https://his.diva-portal.org/smash/get/diva2:1039439/FULLTEXT01.pdf

المؤلفون: Starokozhko, Viktoriia, Vatakuti, Suresh, Schievink, Bauke, Merema, Marjolijn T., Asplund, Annika, Synnergren, Jane, Aspegren, Anders, Groothuis, Geny M. M.

المصدر: Archives of Toxicology. July 2017 91(7):2711-2711

المؤلفون: Schievink, Bauke, de Zeeuw, Dick, Smink, Paul A, Andress, Dennis, Brennan, John J, Coll, Blai, Correa-Rotter, Ricardo, Hou, Fan Fan, Kohan, Donald, Kitzman, Dalane W, Makino, Hirofumi, Parving, Hans-Henrik, Perkovic, Vlado, Remuzzi, Giuseppe, Tobe, Sheldon, Toto, Robert, Hoekman, Jarno, Lambers Heerspink, Hiddo J, Innovation Studies, Innovation and Sustainability

المساهمون: Groningen Kidney Center (GKC), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Innovation Studies, Innovation and Sustainability

المصدر: European Journal of Preventive Cardiology, 23, 758. SAGE Publications Inc.
European Journal of Preventive Cardiology, 23(7), 758-768. SAGE Publications Inc.
Eur J Prev Cardiol

مصطلحات موضوعية: Endothelin Receptor Antagonists, Male, Pyrrolidines, Time Factors, Epidemiology, 030232 urology & nephrology, Type 2 diabetes, 030204 cardiovascular system & hematology, Kidney, law.invention, Diabetic nephropathy, 0302 clinical medicine, Randomized controlled trial, renal disease, law, cardiovascular disease, Taverne, ANGIOTENSIN RECEPTOR BLOCKERS, Medicine, DRUG, Middle Aged, Treatment Outcome, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, medicine.drug, Glomerular Filtration Rate, medicine.medical_specialty, Urology, Article, albuminuria, Nephropathy, DIABETIC-NEPHROPATHY, 03 medical and health sciences, Diabetes mellitus, Humans, Renal Insufficiency, Chronic, Intensive care medicine, Aged, ANTAGONIST, Heart Failure, Dose-Response Relationship, Drug, business.industry, atrasentan, Atrasentan, medicine.disease, Clinical trial, Diabetes Mellitus, Type 2, Albuminuria, business, Biomarkers, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e61dfc811c6438c66a5031b04242328
https://dspace.library.uu.nl/handle/1874/407330

المؤلفون: Schievink, Bauke

المساهمون: de Zeeuw, Dick, Lambers Heerspink, Hiddo

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::790be716dbf7681b4e599bcfe57141fb
https://research.rug.nl/en/publications/501710e8-75e7-4983-bfa9-c3c2cab961e3

المؤلفون: Schievink, Bauke, de Zeeuw, Dick, Parving, Hans-Henrik, Rossing, Peter, Lambers Heerspink, Hiddo

المساهمون: Groningen Kidney Center (GKC), Methods in Medicines evaluation & Outcomes research (M2O), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

المصدر: British Journal of Clinical Pharmacology, 80(4), 678-686. Wiley

مصطلحات موضوعية: ALBUMINURIA, IDNT TRIALS, POST-HOC ANALYSIS, BLOOD-PRESSURE, personalized medicine, urologic and male genital diseases, CARDIOVASCULAR PROTECTION, EFFICACY, THERAPY, female genital diseases and pregnancy complications, DIABETIC-NEPHROPATHY, angiotensin receptor blockers, REDUCTION, renal disease, type 2 diabetes, LOSARTAN

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::a05ebf571ce7d254f7822dd73a45b614
https://research.rug.nl/en/publications/53d0141d-ded8-4099-bd77-098771f18afb

المؤلفون: Schievink, Bauke

المصدر: Schievink , B 2016 , ' Integrating biomarkers to predict renal and cardiovascular drug efficacy : PRE score applications from drug registration to personalized medicine ' , Doctor of Philosophy , University of Groningen , [Groningen] .

مصطلحات الفهرس: doctoralThesis

URL: http://hdl.handle.net/11370/501710e8-75e7-4983-bfa9-c3c2cab961e3

المؤلفون: Schievink, Bauke, Heerspink, Hiddo Lambers, Leufkens, Bert, De Zeeuw, Dick, Hoekman, Jarno, UIPS - Utrecht Institute for Pharmaceutical Sciences, Innovation Studies, Sub Pharmacoepidemiology, Innovation and Sustainability, Pharmacoepidemiology and Clinical Pharmacology

المساهمون: Groningen Kidney Center (GKC), Methods in Medicines evaluation & Outcomes research (M2O), UIPS - Utrecht Institute for Pharmaceutical Sciences, Innovation Studies, Sub Pharmacoepidemiology, Innovation and Sustainability, Pharmacoepidemiology and Clinical Pharmacology

المصدر: PLoS ONE, Vol 9, Iss 9, p e108722 (2014)
PLoS ONE, 9(9):e108722. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS One, 9(9). Public Library of Science

مصطلحات موضوعية: Male, Biomedical Research, DUAL RAS BLOCKADE, Alternative medicine, lcsh:Medicine, Blood Pressure, Disease, Computer-assisted web interviewing, 030204 cardiovascular system & hematology, Bioinformatics, Biochemistry, 0302 clinical medicine, Surveys and Questionnaires, Medicine and Health Sciences, Medicine, 030212 general & internal medicine, lcsh:Science, Drug Approval, Pharmaceutical industry, Netherlands, Medicine(all), RISK, OUTCOMES, Multidisciplinary, Agricultural and Biological Sciences(all), Health Systems Agencies, Middle Aged, 3. Good health, C-Reactive Protein, Cardiovascular Diseases, CARDIOVASCULAR-DISEASE, Practice Guidelines as Topic, Biomarker (medicine), Female, Kidney Diseases, CLINICAL-TRIALS, Research Article, Adult, medicine.medical_specialty, Drug Research and Development, Drug Industry, SAFETY TESTING CONSORTIUM, BIOMARKERS, Likert scale, 03 medical and health sciences, RESPONSE RATES, Albuminuria, Humans, DRUG DEVELOPMENT, Aged, Drug Regulation, Glycated Hemoglobin, Pharmacology, Public Sector, Surrogate endpoint, business.industry, Biochemistry, Genetics and Molecular Biology(all), lcsh:R, Drugs, Investigational, Clinical trial, MYOCARDIAL-INFARCTION, Family medicine, lcsh:Q, business, Genetics and Molecular Biology(all)

وصف الملف: application/pdf; image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb4d4466f0755f27b3ef76e02dccc5bd
https://doi.org/10.1371/journal.pone.0108722

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schievink B; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands., de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands., Smink PA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands., Andress D; Renal Clinical Development, Abbvie, North Chicago, USA., Brennan JJ; Renal Clinical Development, Abbvie, North Chicago, USA., Coll B; Renal Clinical Development, Abbvie, North Chicago, USA., Correa-Rotter R; National Medical Science and Nutrition Institute Salvador Zubiran, Mexico City, Mexico., Hou FF; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, China., Kohan D; Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, USA., Kitzman DW; Cardiology Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, USA., Makino H; Okayama University Hospital, Japan., Parving HH; Department of Medical Endocrinology Rigshospitalet, University Hospital of Copenhagen, Denmark., Perkovic V; The George Institute for International Health, The University of Sydney, Australia., Remuzzi G; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Bergamo, Italy; Unit of Nephrology, Dialysis and Transplantation, AO Papa Giovanni XXIII, Bergamo, Italy., Tobe S; Sunnybrook Health Sciences Center, Toronto, Canada., Toto R; University of Texas Southwestern Medical Center, Dallas, USA., Hoekman J; Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, The Netherlands., Lambers Heerspink HJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands H.J.Lambers.Heerspink@umcg.nl.

المصدر: European journal of preventive cardiology [Eur J Prev Cardiol] 2016 May; Vol. 23 (7), pp. 758-68. Date of Electronic Publication: 2015 Jul 30.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*complications , Glomerular Filtration Rate/*drug effects , Heart Failure/*drug therapy , Pyrrolidines/*administration & dosage , Renal Insufficiency, Chronic/*prevention & control, Aged ; Atrasentan ; Biomarkers/metabolism ; Diabetes Mellitus, Type 2/metabolism ; Dose-Response Relationship, Drug ; Endothelin Receptor Antagonists/administration & dosage ; Female ; Follow-Up Studies ; Heart Failure/complications ; Heart Failure/physiopathology ; Humans ; Kidney/physiopathology ; Male ; Middle Aged ; Renal Insufficiency, Chronic/etiology ; Renal Insufficiency, Chronic/physiopathology ; Time Factors ; Treatment Outcome

المؤلفون: Schievink B; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Parving HH; Department of Medical Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen.; Department of Medical Endocrinology, Rigshospitalet, HEALTH, Aarhus University, Aarhus, Denmark., Rossing P; Steno Diabetes Center, Gentofte, NNF Center for Basic Metabolic Research University of Copenhagen, Copenhagen, HEALTH, Aarhus University, Aarhus., Lambers Heerspink HJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2015 Oct; Vol. 80 (4), pp. 678-86. Date of Electronic Publication: 2015 May 28.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Angiotensin Receptor Antagonists/*pharmacology , Kidney/*drug effects , Kidney Failure, Chronic/*prevention & control , Potassium/*blood, Adult ; Aged ; Albuminuria/drug therapy ; Angiotensin Receptor Antagonists/therapeutic use ; Biomarkers ; Biphenyl Compounds/pharmacology ; Biphenyl Compounds/therapeutic use ; Blood Pressure/drug effects ; Cholesterol/blood ; Creatinine/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/physiopathology ; Female ; Hemoglobins/drug effects ; Humans ; Individuality ; Irbesartan ; Losartan/pharmacology ; Losartan/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Tetrazoles/pharmacology ; Tetrazoles/therapeutic use ; Uric Acid/blood